Loperamide

Journal of Pain and Symptom Management

Volumn 42, Issue 2, 2011, Pages 319-323

  Regnard, Claud ^a   Twycross, Robert ^b   Mihalyo, Mary ^c   Wilcock, Andrew ^d  

^a St Oswald's Hospice   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c DUQUESNE UNIVERSITY   (United States)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; CLOZAPINE; CODEINE; CYCLOSPORIN; CYTOCHROME P450 3A4; DIPHENOXYLATE; ERYTHROMYCIN; FLUCONAZOLE; GLYCOPROTEIN P; ITRACONAZOLE; KETOCONAZOLE; LOPERAMIDE; OCTREOTIDE; OPIATE RECEPTOR; QUINIDINE; RITONAVIR; SIMETHICONE; VERAPAMIL;

ABDOMINAL DISCOMFORT; ACUTE DIARRHEA; CHRONIC DIARRHEA; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENCY; DRUG TOLERANCE; FECES IMPACTION; HUMAN; ILEOSTOMY; ILEUS; REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; URINE RETENTION;

EID: 79961008423     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2011.06.001     Document Type: Short Survey

References (31)

1. Shannon H, Lutz E. Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats. Neuropharmacology 2001;42:253-261.
2. Van Nueten JM, Helsen L, Michiels M, Heykants JJ. Distribution of loperamide in the intestinal wall. Biochem Pharmacol 1979;28:1433-1434. (Pubitemid 9174323)
3. Ooms LA, Degryse AD, Janssen PA. Mechanisms of action of loperamide. Scand J Gastroenterol Suppl 1984;96:145-155. (Pubitemid 14065824)
4. Hallgren T, Fasth S, Delbro DS, et al. Loperamide improves anal sphincter function and continence after restorative proctocolectomy. Dig Dis Sci 1994;39:2612-2618.
5. Dashwood MR, Sykes RM, Thomson CS. Autoradiographic demonstration of [3H] loperamide binding to opioid receptors in rat and human small intestine. Prog Clin Biol Res 1990;328:165-169.
6. Merritt JE, Brown BL, Tomlinson S. Loperamide and calmodulin. Lancet 1982;1:283. (Pubitemid 12205295)
7. Zavecz JH, Jackson TE, Limp GL, Yellin TO. Relationship between anti-diarrheal activity and binding to calmodulin. Eur J Pharmacol 1982;78:375-377. (Pubitemid 12190701)
8. Daly J, Harper J. Loperamide: novel effects on capacitative calcium influx. Cell Mol Life Sci 2000;57:149-157. (Pubitemid 30105334)
9. Klaren PH, Giesberts AN, Chapman J, et al. Effect of loperamide on Na+/D-glucose cotransporter activity in mouse small intestine. J Pharm Pharmacol 2000;52:679-686. (Pubitemid 30410082)
10. Tan-No K, Niijima F, Nakagawasai O, et al. Development of tolerance to the inhibitory effect of loperamide on gastrointestinal transit in mice. Eur J Pharm Sci 2003;20:357-363. (Pubitemid 37338542)
11. Heel RC, Brogden RN, Speight TM, Avery GS. Loperamide: a review of its pharmacological properties and therapeutic efficacy in diarrhoea. Drugs 1978;15:33-52. (Pubitemid 8260089)
12. Heykants J, Michiels M, Knaeps A, Brugmans J. Loperamide (R 18553), a novel type of antidiarrheal agent. Part 5: The pharmacokinetics of loperamide in rats and man. Arzneimittelforschung 1974;24:1649-1653.
13. Sadeque AJ, Wandel C, He H, Shah S, Wood AJ. Increased drug delivery to the brain by P-glycoprotein inhibition. Clin Pharmacol Ther 2000;68:231-237.
14. Nozaki-Taguchi N, Yaksh TL. Characterization of the antihyperalgesic action of a novel peripheral mu-opioid receptor agonist e loperamide. Anesthesiology 1999;90:225-234.
15. Nozaki-Taguchi N, Shutoh M, Shimoyama N. Potential utility of peripherally applied loperamide in oral chronic graft-versus-host disease related pain. Jpn J Clin Oncol 2008;38:857-860.
16. Regnard C. Personal communication. Newcastle: St. Oswald's Hospice, 2011.
17. Benson AB 3rd, Ajani JA, Catalano RB, et al. Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol 2004;22:2918-2926. (Pubitemid 41079912)
18. Maroun JA, Anthony LB, Blais N, et al. Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea. Curr Oncol 2007;14:13-20.
19. Murphy E, Prommer EE, Mihalyo M, Wilcock A. Octreotide. J Pain Symptom Manage 2010;40:142-148.
20. Bhattacharya S, Vijayasekar C, Worlding J, Mathew G. Octreotide in chemotherapy induced diarrhoea in colorectal cancer: a review article. Acta Gastroenterol Belg 2009;72:289-295.
21. Schuermans V, Van Lommel R, Dom J, Brugmans J. Loperamide (R18553), a novel type of antidiarrhoeal agent. Part 6: clinical pharmacology. Placebo-controlled comparison of the constipating activity and safety of loperamide, diphenoxylate and codeine in normal volunteers. Arzneimittelforschung 1974;24:1653-1657.
22. Kaplan MA, Prior MJ, Ash RR, et al. Loperamidesimethicone vs loperamide alone, simethicone alone, and placebo in the treatment of acute diarrhea with gasrelated abdominal discomfort. A randomized controlled trial. Arch Fam Med 1999;8:243-248.
23. Hanauer SB, DuPont HL, Cooper KM, Laudadio C. Randomized, double-blind, placebo-controlled clinical trial of loperamide plus simethicone versus loperamide alone and simethicone alone in the treatment of acute diarrhea with gas-related abdominal discomfort. Curr Med Res Opin 2007;23:1033-1043. (Pubitemid 46799585)
24. Dreverman JWM, van der Poel AJ. Loperamide oxide in acute diarrhoea: a double-blind placebo-controlled trial. Aliment Pharmacol Ther 1995;9:441-446.
25. Killinger JM, Weintraub HS, Fuller BL. Human pharmacokinetics and comparative bioavailability of loperamide hydrochloride. J Clin Pharmacol 1979;19:211-218. (Pubitemid 9172217)
26. Baker DE. Loperamide: a pharmacological review. Rev Gastroenterol Dis 2007;7(Suppl 3):s11-18.
27. Vandenbossche J, Huisman M, Xu Y, Sanderson-Bongiovanni D, Soons P. Loperamide and P-glycoprotein inhibition: assessment of the clinical relevance. J Pharm Pharmacol 2010;62:401-412.
28. Friedli G, Haenggeli CA. Loperamide overdose managed by naloxone. Lancet 1980;1(8183):1413. (Pubitemid 10069474)
29. Minton N,Smith P. Loperamide toxicity in a child after a single dose. BrMed J (ClinRes Ed) 1987;294(6584):1383.
30. Litovitz T, Clancy C, Korberly B, Temple AR, Mann KV. Surveillance of loperamide ingestions: an analysis of 216 poison center reports. J Toxicol Clin Toxicol 1997;35:11-19. (Pubitemid 27063978)
31. Eronen M, Putkonen H, Hallikainen T, Vartiainen H. Lethal gastroenteritis associated with clozapine and loperamide. Am J Psychiatry 2003;160:2242-2243.